Novartis re-launches compliance program to fight high blood pressure

Share this article:
Novartis has embarked "on a mission" to fight hypertension while backing its best- selling product, the blood-pressure-lowering medication Diovan, according to the drugmaker's top financial official.
"We are on a mission in hypertension because we think there is a lot of unmet (patient) need," said Novartis chief operating officer Alex Gorsky speaking at Bear Stearns' annual healthcare conference in New York yesterday. "We think keeping patients on their medication is an important step."
To help achieve its goal of "lowering America's blood pressure," Novartis rebranded and reformatted its Healthy BP patient education program as the BP Success Zone. The renamed program featuring a new compliance program in was launched in July.
"The results have been impressive," Gorsky said. "We've (already) seen increased enrollment."
BP Success Zone helps patients by providing medication, a free Omron blood pressure monitor with rebate, customized patient education that features lifestyle modification action plans, and a members' Web site with blood pressure tracking tools.
The new compliance component to the program helps promote smoking cessation, a low salt diet, exercise, weight reduction and stress reduction.
Diovan is Novartis' top-selling product with global sales in the 12 months to June 2005 topping the $1.7 billion dollar mark, according to company figures.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.